Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06919042 · ClinicalTrials.gov registry record · NA
Shockwave in Postoperative Breast Reconstruction Fibrosis
A NA study of Fibrosis Breast, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06919042 is a NA study of Fibrosis Breast that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06919042, a NA study of Fibrosis Breast, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the potential for extracorporeal shockwave therapy to reduce post-operative soft tissue fibrosis.
Conditions Studied
Interventions
- DEVICE Pulsed Acoustic Cellular Expression therapy
Study Locations (1)
Illinois
- Lavin Pavilion Suite 2060 - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2026-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06919042
The ClinicalTrials.gov registry entry for NCT06919042 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fibrosis Breast appearing as the primary indexed condition, and to 1 intervention - of which Pulsed Acoustic Cellular Expression therapy is the first listed.
NCT06919042 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06919042 about?
NCT06919042 is a clinical study titled "Shockwave in Postoperative Breast Reconstruction Fibrosis". This study evaluates the potential for extracorporeal shockwave therapy to reduce post-operative soft tissue fibrosis.
What is the current status of trial NCT06919042?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-10-01. Estimated completion is 2026-09.
What conditions does trial NCT06919042 study?
This clinical trial studies the following conditions: Fibrosis Breast.
What interventions are being tested in trial NCT06919042?
The interventions under investigation include: Pulsed Acoustic Cellular Expression therapy (DEVICE).
Who is sponsoring clinical trial NCT06919042?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06919042 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.